- Home
- APYX vs INMB Comparison
APYX vs INMB Comparison
Compare APYX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- INMB
- Stock Information
- Founded
- APYX 1982
- INMB 2015
- Country
- APYX United States
- INMB United States
- Employees
- APYX N/A
- INMB N/A
- Industry
- APYX Medical/Dental Instruments
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- APYX Health Care
- INMB Health Care
- Exchange
- APYX Nasdaq
- INMB Nasdaq
- Market Cap
- APYX 84.7M
- INMB 68.9M
- IPO Year
- APYX 1987
- INMB 2019
- Fundamental
- Price
- APYX $2.15
- INMB $2.31
- Analyst Decision
- APYX Hold
- INMB Buy
- Analyst Count
- APYX 2
- INMB 4
- Target Price
- APYX N/A
- INMB $9.53
- AVG Volume (30 Days)
- APYX 96.0K
- INMB 6.9M
- Earning Date
- APYX 08-07-2025
- INMB 07-31-2025
- Dividend Yield
- APYX N/A
- INMB N/A
- EPS Growth
- APYX N/A
- INMB N/A
- EPS
- APYX N/A
- INMB N/A
- Revenue
- APYX $47,288,000.00
- INMB $50,000.00
- Revenue This Year
- APYX $2.25
- INMB $82.14
- Revenue Next Year
- APYX $6.76
- INMB $28,750.98
- P/E Ratio
- APYX N/A
- INMB N/A
- Revenue Growth
- APYX N/A
- INMB N/A
- 52 Week Low
- APYX $0.76
- INMB $1.89
- 52 Week High
- APYX $2.73
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- APYX 54.50
- INMB 26.84
- Support Level
- APYX $2.12
- INMB $2.22
- Resistance Level
- APYX $2.73
- INMB $2.49
- Average True Range (ATR)
- APYX 0.26
- INMB 0.94
- MACD
- APYX -0.00
- INMB -0.24
- Stochastic Oscillator
- APYX 40.63
- INMB 4.31
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.